Drawing for ZENEUS

USPTO serial 78487059

ZENEUS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SNAPP, TINA LOUISE
Law office
TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ZENEUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael S. Hargis

MICHAEL S HARGIS KING & SCHICKLI PLLC247 N BROADWAYLEXINGTON, KY 40507-1058UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of infectious diseases, fungal infections, immune disorders, cardiovascular disease, and for dermatology, hematology,oncology, mental health, neurology and pain control use; pharmaceutical preparations,namely, vaccines, immunotherapeutics and biologics in the nature of protein, polypeptide and nucleic acid-based pharmaceuticals for the treatment of infectious diseases, fungal infections, immune disorders, cardiovascular disease, and for dermatology, hematology;oncology, mental health, neurology and pain control use; dietetic foods adapted for medical use, food for babies; medical plasters, dressings for bums and wounds; material for stopping teeth, dental wax; all-purpose disinfectants; preparations for destroying vermin; fungicides for domestic and agricultural use; and herbicidesACTIVE—
035Advertising; business management; business administration; office functions; marketing and promotional services; administration relating to sales methods; advisory services relating to sales promotion; consultancy relating to sales promotions; provision of sales analyses; sales promotion servicesACTIVE—
042Scientific research and development; technological research and development in the field of medicine and pharmaceuticals; medical and pharmaceutical industrial analysis and research services; legal services; reviewing standards and practices to assure compliance with pharmaceutical laws and regulations; compiling regulatory information for others in the field of medicine and pharmaceuticals; advisory services relating to regulatory affairs; advisory services relating to regulatory affairs in the field of pharmaceuticals; laboratory research services relating to pharmaceuticals; research relating to pharmaceuticals; testing and inspection of pharmaceuticals for assessing the efficiency and safety of pharmaceuticals; and pharmaceutical product evaluationACTIVE—
044Medical services; beauty salon services; animal grooming services; and advisory and information services relating to pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 9, 2006MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 9, 2006ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 12, 2006CNSIINQUIRY AS TO SUSPENSION MAILED—
Apr 12, 2006CNSISUSPENSION INQUIRY WRITTEN—
Apr 12, 2006RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 12, 2005GRMLCORRESPONDENCE E-MAILED—
Oct 12, 2005CNSLSUSPENSION LETTER WRITTEN—
Oct 6, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 26, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 26, 2005MAILPAPER RECEIVED—
Apr 25, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2005DOCKASSIGNED TO EXAMINER—
Sep 29, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance